About Us
We are experts in mass spectrometry, bioinformatics, data science, RNA and protein chemistry and modern software engineering. We are transforming mass spectrometry data analysis workflows and creating the future.
Participate in the Future of Mass Spectrometry Data Analysis Software
Participate with us in creating a new world of MS-based data analysis software. Software that accelerates, rather than slows down, life science R&D. Software that is intuitive and accessible from anywhere. Software that enables collaboration, breaks-down data silos, integrates easily and builds organizational knowledge. Software that brings confident results and peace of mind. And yes…software that is affordable so that anyone with a need…even an occasional one….is able to participate and benefit.
How? Contact us. Talk to us. Try mmBiologics. Tell us about your workflow challenges. Collaborate. Let’s create this new world together.
MassMatrix provides novel bioscience data analysis software solutions on an informatics cloud platform that boosts research, discovery, development, and quality control of production of new synthetic RNA and conjugate drugs and therapies.
MassMatrix professional services include bioinformatics consulting and contracting for biodata analysis and custom multi-omic workflow development. We encourage engaging in collaborations for creating novel capabilities to meet the emerging R&D needs.
Direct sequencing via high-resolution mass spectrometry is an essential assay in R&D and QA/QC of new oligonucleotide therapeutics.
Manual intervention in the analysis pipeline due to inadequate software causes bottlenecks in creating and delays in getting new therapeutics to market.
In-depth characterization of RNA and modifications for improving biomarker identification is hindered in research by lack of advanced solutions.
MassMatrix’s novel solutions are provided on a secure cloud platform. They enable semi-automated direct sequencing of mass spectrometry data. Our solution applies novel XIC, deconvolution, and sequencing algorithms for speedy, highly accurate and precise analysis of new synthetic oligonucleotides and conjugates.
Our workflow engine characterizes nonstandard, hybrid, and conjugate oligonucleotides, enabling design and delivery of new drugs, vaccines, and therapies. A unified data repository enables sample comparisons, knowledge capture and management, and collaboration among researchers.
These capabilities improve reliability and eliminate characterization bottlenecks. They are available by subscribing to our secure online service or by licensing them to deploy on customers’ private enterprise networks.
Our unique, multiomic, analytic software and informatics tools help users achieve deeper understanding and better decision-making as the develop their new offerings. With MassMatrix they can optimize resource use and bottom-line impact in R&D and manufacturing.
Our solutions aim to improve collaboration among researchers as they work to improve safety, efficacy, and availability of lifesaving and enhancing drugs, vaccines, and therapies.
Our tools and services help users save weeks and even months of time and millions in funding by speeding up needed discovery and development to deliver healthcare outcomes quicker.
Our Team
A descriptive paragraph that tells clients how good you are and proves that you are the best choice that they’ve made.
G. Hall Johnson
Co-founder / Chief Executive Officer
Professor Michael A. Freitas, Ph.D.
Co-founder / Chief Science Officer
Herman Singh
Director of Engineering
Scientific Advisors
Dr. Juan D. Alfonzo
Executive Director, Brown RNA Center
Prof. Patrick A Limbach
Professor and Vice President for Research, University of Cincinnati
Kim Alving, Ph.D.
Biopharma Scientific Advisor
Passion Is What Drives Us
We’re not just determined about doing great work.
We also love doing it.